Development of a Recombinase Polymerase Amplification Assay for Rapid Detection of the Mycobacterium avium subsp.

Sören Hansen1, Jenny Schäfer1, Kim Fechner1

  • 1Division of Microbiology and Animal Hygiene, Institute of Veterinary Medicine, Department of Animal Sciences, Faculty of Agricultural Sciences, Georg-August University, Goettingen, Germany.

Plos One
|December 20, 2016
PubMed
Abstract

Insights

A new rapid recombinase polymerase amplification (RPA) assay detects Mycobacterium avium subsp. paratuberculosis (MAP) in 15 minutes. This assay offers high specificity and sensitivity for MAP detection in ruminants, improving disease control.

Area of Science:

  • Veterinary Microbiology
  • Molecular Diagnostics
  • Infectious Disease Control

Background:

  • Accurate detection of Mycobacterium avium subsp. paratuberculosis (MAP) is vital for controlling its spread in ruminants and preventing human transmission.
  • Traditional MAP detection methods like cultivation are time-consuming, while existing PCR assays require complex equipment and procedures.
  • There is a need for rapid, accessible diagnostic tools for MAP infections.

Purpose of the Study:

  • To develop and evaluate a rapid diagnostic assay for Mycobacterium avium subsp. paratuberculosis (MAP) detection.
  • To assess the performance of a recombinase polymerase amplification (RPA) assay targeting the IS900 gene for MAP identification.

Main Methods:

  • Development of a recombinase polymerase amplification (RPA) assay targeting the IS900 gene specific to MAP.
  • Determination of the assay's detection limit using plasmid standards and probit analysis.
  • Evaluation of clinical performance using blood, sperm, fecal, and tissue samples from MAP-infected and non-infected ruminants, compared against real-time PCR.

Main Results:

  • The MAP RPA assay achieved a detection limit of 16 DNA molecules in 15 minutes.
  • No cross-reactivity was observed with other mycobacterial or bacterial strains.
  • The assay demonstrated 100% specificity and 89.5% sensitivity when tested with clinical samples.

Conclusions:

  • The developed RPA assay provides a rapid, user-friendly alternative to traditional MAP detection methods.
  • Reagents are cold-chain independent, enhancing its utility in various settings.
  • Combined with a simple extraction protocol, the RPA assay is suitable for point-of-need MAP detection.

Related Concept Videos